Live feed
·
INSIDERFilingvia Quantisnow
9 Meters Biopharma Inc. logo

9 Meters Biopharma (NMTR) director Sirgo bought 20,000 shares for $21.2K at $1.06

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Mark A Sirgo (director at 9 Meters Biopharma Inc., NMTR) reported that they bought 20,000 shares for $21.2K at $1.06 on Nov 18, 2021. After these transactions the filing shows 1,192,595 shares held directly.

Reporting person
Sirgo Mark A
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Nov 18, 2021Open-market purchase (P)Common stock+20,000$1.06$21.2K1,192,595 direct

Holdings before and after

  • Common stock: 1,172,595 to 1,192,595 direct

Other positions listed

  • Common stock: 21,485 indirect, by spouse

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Sirgo report in this NMTR Form 4?

Mark A Sirgo (director at 9 Meters Biopharma Inc., NMTR) reported that they bought 20,000 shares for $21.2K at $1.06 on Nov 18, 2021. After these transactions the filing shows 1,192,595 shares held directly.

How many NMTR shares does Sirgo hold after this filing?

The filing shows 1,192,595 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for NMTR

Earlier insider filings at NMTR

Quantisnow market dataNASDAQ
9 Meters Biopharma Inc. logo
NMTR
9 Meters Biopharma Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2018
Get push alerts for NMTR

Follow NMTR and get a push notification the moment its next story breaks.

Full NMTR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NMTR (9 Meters Biopharma Inc.) and more on Quantisnow.